# Spinal Cord Injury Neuroprotection With Glyburide

> **NCT02524379** · PHASE1,PHASE2 · TERMINATED · sponsor: **Ohio State University** · enrollment: 3 (actual)

## Conditions studied

- Acute Spinal Cord Injury

## Interventions

- **DRUG:** Glyburide

## Key facts

- **NCT ID:** NCT02524379
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-14
- **Primary completion:** 2021-02-08
- **Final completion:** 2021-02-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Principal investigator has left the university; there were not enough participants to analyze the data.
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524379, "Spinal Cord Injury Neuroprotection With Glyburide". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02524379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*